Albany, NY -- (SBWIRE) -- 01/15/2019 -- DelveInsight has announced the addition of the "Peanut Allergy (PA) - Market Insights, Epidemiology and Market Forecast- 2027" drug pipelines to their offering.

Report provides an overview of the disease and market size of PA for the seven major markets i.e., United States, EU5 (Germany, France, Italy, Spain, and United Kingdom) and Japan. The Report covers the overview, treatment practice and PA forecasted epidemiology from 2018 to 2027 segmented by the seven major markets.

A Peanut Allergy is an allergic reaction to peanuts which occurs when the human body mistakenly identifies peanuts as harmful substances. Peanuts are not the same as tree nuts (almonds, cashews, walnuts, etc.), which grow on trees. In botanical terms, the peanut is not a nut, but a legume. It is one of the types of food that often provoke severe allergic reactions. In some cases, trace amounts of one milligram can trigger a reaction. The allergic components in peanuts are specific identified proteins. Peanut proteins that activate the immunological response are classified as major or minor allergens. The symptoms of peanut allergy vary from mild to severe, from swollen lips, Itchy skin or hives, which can appear as small spots or large welts, an itching or tingling sensation in or around the mouth or throat, shortness of breath to an anaphylactic shock, which is potentially fatal. Symptoms of the allergy are only induced when people with a peanut allergy eat products that contain peanuts. In adults, female population is more susceptible to this allergy than male.

According to DelveInsight, total prevalent population of Peanut Allergy (PA) in the 7 major markets ranges from approximately 6,754 cases in 2016. DelveInsight also estimates highest prevalence of Peanut Allergy (PA) in the United States in 2016. There were around 3,238 thousand patients in United States in 2015 who experienced Peanut Allergy due to one or the other reason. These cases are expected to increase by 2027. Among the European countries, Germany had the highest prevalent population of Peanut Allergy (PA). Total prevalent cases of Germany of PA were 1,058 thousand in 2016 and is estimated to decrease by 2027. According to DelveInsight, among children, male prevalence for PA is more than females, which is opposite in adult population. In adults, female population is more susceptible to this allergy than male. As per DelveInsight estimates, the prevalence rate of PA is observed to be higher in children of 0-4 years of age group than children between 5-14 years.

The market size of Peanut Allergy (PA) in the seven major markets is expected to increase by 2027 from USD 5,086 million in 2016. The United States accounts for the largest market size of PA in comparison with the EU5 (the United Kingdom, Germany, Italy, France, and Spain) and Japan. In 2016, the US market for Peanut Allergy was around USD 3,213 million, which is estimated to increase by 2027.
Geography Covered

1. The United States
2. EU5 (Germany, France, Italy, Spain and the United Kingdom)
3. Japan
Study Period: 2016-2027
Drug Companies

1. Aimmune Therapeutics
2. Prota Therapeutics
3. AnaptysBio
4. Genentech
5. DBV Technologies
And many others

Drugs covered

1. AR101
2. Viaskin Peanut
3. PPOIT
4. ANB020
5. Omalizumab
And many others

Report Scope

The report covers the descriptive overview of PA explaining its pathophysiology, disease classification, diagnostic approaches and treatment algorithm. Comprehensive insight has been provided into the epidemiology of the PA and its treatment in the 7 MM, covering the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom) & Japan. Additionally, an all-inclusive account of both the current and emerging therapies for PA are provided, along with assessment of the impact new therapies will have on the current treatment landscape. A detailed review of global historical and forecasted PA market is included in the report, covering drug outreach in the 7 MM. The report provides an edge while developing business strategies, by understanding trends shaping and driving the global PA market.